Dronabinol

"Dronabinol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.

Descriptor ID	D013759
MeSH Number(s)	D02.455.849.090.810
Concept/Terms	Dronabinol Dronabinol delta(9)-THC 9-ene-Tetrahydrocannabinol 9 ene Tetrahydrocannabinol THC delta(1)-Tetrahydrocannabinol delta(1)-THC delta(9)-Tetrahydrocannabinol Tetrahydrocannabinol Tetrahydrocannabinol, (6a-trans)-Isomer Tetrahydrocannabinol, (6a-trans)-Isomer Tetrahydrocannabinol, Trans-Isomer Tetrahydrocannabinol, Trans-Isomer Tetrahydrocannabinol, Trans Isomer Tetrahydrocannabinol, (6aS-cis)-Isomer Tetrahydrocannabinol, (6aS-cis)-Isomer Tetrahydrocannabinol, Trans-(+-)-Isomer Tetrahydrocannabinol, Trans-(+-)-Isomer Marinol Marinol Tetrahydrocannabinol, (6aR-cis)-Isomer Tetrahydrocannabinol, (6aR-cis)-Isomer

Below are MeSH descriptors whose meaning is more general than "Dronabinol".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Hydrocarbons [D02.455]
Terpenes [D02.455.849]
Cannabinoids [D02.455.849.090]
Dronabinol [D02.455.849.090.810]

Below are MeSH descriptors whose meaning is related to "Dronabinol".

Below are MeSH descriptors whose meaning is more specific than "Dronabinol".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Dronabinol" by people in this website by year, and whether "Dronabinol" was a major or minor topic of these publications.

Bar chart showing 127 publications over 26 distinct years, with a maximum of 9 publications in 2011 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1998	1	1	2
2001	4	0	4
2003	2	0	2
2004	3	0	3
2005	2	0	2
2006	3	0	3
2007	3	1	4
2008	2	0	2
2009	7	0	7
2010	5	1	6
2011	5	4	9
2012	5	3	8
2013	6	3	9
2014	4	4	8
2015	3	2	5
2016	1	7	8
2017	3	1	4
2018	3	0	3
2019	0	2	2
2020	4	4	8
2021	1	7	8
2022	3	5	8
2023	0	5	5
2024	4	1	5
2025	1	0	1

Below are the most recent publications written about "Dronabinol" by people in Profiles.

Aks IR, Patel H, Pelham WE, Huestis MA, Wade NE. Cannabinoids in hair and their prospective association with mental and physical health outcomes in adolescents. Neurotoxicol Teratol. 2025 Mar-Apr; 108:107433.

View in: PubMed
Sempio C, Campos-Palomino J, Klawitter J, Harrison A, Peters EN, MacNair L, Haghdoost M, Bonn-Miller M, Babalonis S, Huestis MA, Christians U, Klawitter J. LC-MS-MS quantification of ?8-THC, ?9-THC, THCV isomers and their main metabolites in human plasma. J Anal Toxicol. 2024 Aug 21; 48(7):499-506.

View in: PubMed
Torrens A, Mabou Tagne A, Tran A, Ahmed F, Huestis MA, Piomelli D. Comparative Pharmacokinetics of ?9-Tetrahydrocannabinol in Adolescent and Adult Female Mice. Cannabis Cannabinoid Res. 2024 12; 9(6):1537-1542.

View in: PubMed
Goldman M, Markov DD. Why Ask Patients to Cut Into Quarters 10-mg THC Gummies Obtained From a Cannabis Dispensary When 2.5-mg THC (Dronabinol) Is Available by Prescription? J Clin Psychiatry. 2024 Jun 05; 85(2).

View in: PubMed
Scherer JN, Vasconcelos M, Dalanhol CS, Govoni B, Dos Santos BP, Borges GR, de Gouveia GC, Viola PP, Carlson RLR, Martins AF, Costa JL, Huestis MA, Pechansky F. Reliability of roadside oral fluid testing devices for ?9-tetrahydrocannabinol (?9-THC) detection. Drug Test Anal. 2024 Dec; 16(12):1528-1536.

View in: PubMed
Rozanc J, Klumpers LE, Huestis MA, Tagen M. Tolerability of High-Dose Oral ?9-THC: Implications for Human Laboratory Study Design. Cannabis Cannabinoid Res. 2024 04; 9(2):437-448.

View in: PubMed
Cliburn KD, Kemp PM, Huestis MA, Wagner JR, Payton M, Liu L, Liang Y, Maxwell LK. Time- and?temperature-dependent postmortem ?9-tetrahydrocannabinol concentration changes in?rabbits following controlled inhaled cannabis administration. J Anal Toxicol. 2023 Dec 12; 47(9):850-857.

View in: PubMed
Wade NE, Wallace AL, Huestis MA, Lisdahl KM, Sullivan RM, Tapert SF. Cannabis use and neurocognitive performance at 13-14 Years-Old: Optimizing assessment with hair toxicology in the Adolescent brain cognitive development (ABCD) study. Addict Behav. 2024 03; 150:107930.

View in: PubMed
Marcotte TD, Umlauf A, Grelotti DJ, Sones EG, Mastropietro KF, Suhandynata RT, Huestis MA, Grant I, Fitzgerald RL. Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial. JAMA Psychiatry. 2023 09 01; 80(9):914-923.

View in: PubMed
Hudzik TJ, Huestis MA, Rossi SS, Schumacher YO, Harcourt P, Budgett R, Stuart M, Tettey J, Mazzoni I, Rabin O, Danion A, Culler M, Handelsman D, Thevis M, Kinahan A. Cannabis and sport: A World Anti-Doping perspective. Addiction. 2023 11; 118(11):2040-2042.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement